The research prize, which is worth €15,000 and was donated by Dräger, was presented during the Society’s annual conference.
caption (f.l.t.r.): Dr. Daniel de Backer, Dr. Hermann Heinze, Frank Ralfs
Prof Dr V. Marco Ranieri, President of the ESICM, and Dr. Daniel de Backer, Chairman of the ESICM research committee, awarded the prize together with Frank Ralfs, the leading product manager for respirators at Dräger. This annual prize was created to support research projects relating to intensive care medicine that are dedicated to the progressive treatment of acute respiratory insufficiency. This year the focus was on improving respiration therapy using non-invasive monitoring, and Dr Heinze was awarded the prize to investigate the ’Functional residual capacity guided alveolar recruitment strategy in patients with acute respiratory failure after cardiac surgery1’ over the next 12 months.
Dr Heinze will measure lung volumes in order to study the extent to which managing so-called ‘recruitment manoeuvres2’ can contribute towards making ventilation more effective and cause fewer side effects. Measuring lung volume at the bedside, the so-called functional residual capacity (FRC), has only recently become possible without needing considerable effort. By monitoring the FRC using electric impedance tomography (EIT) for the first time, it should be possible to carry out recruitment manoeuvres in a more targeted manner since this technique provides a continuous, radiation-free and spatial depiction of lung ventilation.
In addition, by analyzing inflammation mediators in blood, the research project aims to prove that applied respiratory manoeuvres provide a less harmful therapy. This is important because inflammation in the lung, and other parts of the body, is a widespread side-effect of ventilation and may be one of the main causes of high mortality in patients with acute respiratory failure.
The winner The 36-year-old prize-winner Dr Hermann Heinze works in the Anesthesiology Clinic at Lübeck University (headed up by Prof Dr P. Schmucker). He will conduct the research project over the coming year jointly with associate professor Dr Wolfgang Eichler. According to Daniel de Backer, chairman of the research committee of the ESICM, “The scientific committee of the ESICM chose this project as it investigates promising, non-invasive approaches of respiratory monitoring, which have the potential to significantly contribute to lung protective ventilation”.
Origin of the prize
The prize is named after Dr Ing. h.c. Bernhard Dräger (1870 – 1928), the son of company founder Heinrich Dräger. In just 28 years, he and his father were awarded 261 German, 443 foreign and 912 utility patents. Bernhard Dräger’s credo was ‘invention is an act of imagination, the creation of something new’. The inventor was also dedicated to science. In 1893 he attended the Technical University in Berlin as a guest student for two semesters to study kinematics, machine elements, tools, and philosophy. This prize aims to help today’s inventors to dedicate themselves to the advancement of clinical science.
Founded in 1889, Drägerwerk AG & Co. KGaA is an international leader in the fields of medical and safety technology. Dräger products protect, support and save human life. In 2007, the Group achieved sales of €1,819.5 million worldwide and an EBIT of €151.9 million. Today, Dräger employs around 10,000 people in more than 70 subsidiaries worldwide and has representation in around 190 countries. The medical division offers products, services and integrated system solutions which accompany the patient throughout the care process – Emergency Care, Perioperative Care, Critical Care or Perinatal care and Home Mechanical Ventilation.
1 The control of the alveolar recruitment strategy based on the functional residual capacity of heart surgery patients with lung failure
2 This is a manoeuver to reopen collapsed lung tissue.Contact for Trade Press
Birgit Diekmann | Drägerwerk
Yuan Chang and Patrick Moore win prize for the discovery of two cancer viruses
14.03.2017 | Goethe-Universität Frankfurt am Main
BMBF funding for diabetes research on pancreas chip
08.02.2017 | Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt
Astronomers from Bonn and Tautenburg in Thuringia (Germany) used the 100-m radio telescope at Effelsberg to observe several galaxy clusters. At the edges of these large accumulations of dark matter, stellar systems (galaxies), hot gas, and charged particles, they found magnetic fields that are exceptionally ordered over distances of many million light years. This makes them the most extended magnetic fields in the universe known so far.
The results will be published on March 22 in the journal „Astronomy & Astrophysics“.
Galaxy clusters are the largest gravitationally bound structures in the universe. With a typical extent of about 10 million light years, i.e. 100 times the...
Researchers at the Goethe University Frankfurt, together with partners from the University of Tübingen in Germany and Queen Mary University as well as Francis Crick Institute from London (UK) have developed a novel technology to decipher the secret ubiquitin code.
Ubiquitin is a small protein that can be linked to other cellular proteins, thereby controlling and modulating their functions. The attachment occurs in many...
In the eternal search for next generation high-efficiency solar cells and LEDs, scientists at Los Alamos National Laboratory and their partners are creating...
Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are less stable. Now researchers at the Technical University of Munich (TUM) have, for the first time ever, produced a composite material combining silicon nanosheets and a polymer that is both UV-resistant and easy to process. This brings the scientists a significant step closer to industrial applications like flexible displays and photosensors.
Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are...
Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to simulate these confined natural conditions in artificial vesicles for the first time. As reported in the academic journal Small, the results are offering better insight into the development of nanoreactors and artificial organelles.
Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to...
20.03.2017 | Event News
14.03.2017 | Event News
07.03.2017 | Event News
27.03.2017 | Earth Sciences
27.03.2017 | Life Sciences
27.03.2017 | Life Sciences